BioWorld - Sunday, December 14, 2025

Infection, BioWorld
Infection, BioWorld RSS Feed RSS

Pediatric exam

Pediatrics group absent from US CDC vaccine discussion

Sep. 18, 2025
By Mari Serebrov
No Comments

The American Academy of Pediatrics (AAP) and a few other medical professional groups were no-shows at the Sept. 18 meeting of the U.S. CDC’s Advisory Committee for Immunization Practices. The absence of the liaison groups was noted, especially that of the AAP. In opening the two-day meeting, ACIP Chair Martin Kulldorff said he lamented that the AAP has ended its association with the committee.


Read More
mRNA vaccines are composed of messenger RNA encapsulated in lipid nanoparticles
Drug design, drug delivery & technologies

Animosity toward mRNA COVID vaccines puts basic science at risk

Sep. 16, 2025
By Mar de Miguel
No Comments
An ongoing concern for scientists is that there will be across-the-board funding cuts. This is already happening in mRNA research, where reductions affected coronavirus-related projects. During the pandemic, efforts focused on this pathogen, and once the health emergency was over, grants for antivirals were eliminated. However, these drugs could stem future outbreaks. Despite the cuts, recent research continues to demonstrate the potential of mRNA, not only for the development of antivirals, but also for obtaining more effective and longer-lasting vaccines.
Read More
Vial and syringe in row of dominoes
Drug design, drug delivery & technologies

The domino effect of cutting mRNA vaccine research

Sep. 15, 2025
By Mar de Miguel
No Comments
In August, a press release from HHS announced the cancellation of 22 vaccine research projects based on mRNA, the latest available technology aimed at developing therapies for viral infections, cancer, and genetic conditions. What happens to mRNA innovation when funding dries up? This series explores how reductions in funding could impact mRNA technology, affecting innovation, research and future therapies.
Read More
Coronavirus punch
Infection

Synthetic carbohydrate receptors as broad-spectrum antivirals

Sep. 4, 2025
By Xavier Bofill Bruna
No Comments
Researchers from the CUNY Advanced Science Research Center and their collaborators recently published a paper in Science Advances on Aug. 27, 2025, about synthetic carbohydrate receptors (SCRs) and their potential as broad-spectrum antivirals by targeting the viral envelope N-glycans. They described the antiviral activity of a series of tetrapodal SCRs both in vitro and in vivo, showing their potential as broad-spectrum inhibitors of viral infection.
Read More
FDA vaccine illustration

Kennedy critic axed from FDA vaccine adcom

Sep. 3, 2025
By Mari Serebrov
No Comments
The vaccine dominoes continue to fall in the U.S. This time one fell on the FDA’s Vaccines and Related Biological Products Advisory Committee, as one of Health and Human Services Secretary Robert Kennedy’s most outspoken critics was removed from the panel nearly a year and a half before his term was to expire.
Read More